Emerging evidences have shown that HE4 is upregulated in ovarian, endometrial, lung, and breast cancer, etc. [1, 5–7]; we thus examined the mRNA level of HE4 in gastric cancer cells by quantitative real-time PCR. Here, WFDC2 is linked to breast carcinoma.